Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Natera (NASDAQ: NTRA), a leader in cell-free DNA and genetic testing, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024. The presentation is scheduled for 7:40 a.m. PT (10:40 a.m. ET) and can be accessed via a live webcast on Natera's investor relations website. A replay will also be available post-event.

Positive

• Natera is presenting at the prestigious Goldman Sachs 45th Annual Global Healthcare Conference, indicating strong industry recognition.
• The event provides Natera with a platform to reach potential investors and highlight its advancements in genetic testing.
• The availability of a live webcast and replay ensures broad accessibility and transparency for shareholders and interested parties.

Negative

• The press release lacks specific financial or clinical data updates, which might leave investors wanting more concrete information.
• There is no mention of new product launches or partnerships, which could have been positive indicators for future growth.

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 7:40 a.m. PT (10:40 a.m. ET).

A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240603615720/en/

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

Source: Natera, Inc.

FAQ

When will Natera present at the Goldman Sachs 45th Annual Global Healthcare Conference?

Natera will present on June 10, 2024, at 7:40 a.m. PT (10:40 a.m. ET).

How can I access Natera's presentation at the Goldman Sachs Conference?

You can access the live webcast through the investor relations section of the Natera website, and a replay will be available shortly after the event.

What is the significance of Natera presenting at the Goldman Sachs Healthcare Conference?

Presenting at the Goldman Sachs Conference highlights Natera's industry recognition and provides a platform to reach potential investors and showcase advancements.